Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $99000.0.

  • Nephros' Cash from Operations rose 11589.09% to $99000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 23102.95%. This contributed to the annual value of -$500000.0 for FY2024, which is 16045.95% down from last year.
  • Latest data reveals that Nephros reported Cash from Operations of $99000.0 as of Q3 2025, which was up 11589.09% from $994000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Cash from Operations ranged from a high of $1.3 million in Q4 2024 and a low of -$1.8 million during Q1 2022
  • In the last 5 years, Nephros' Cash from Operations had a median value of -$170000.0 in 2022 and averaged -$153105.3.
  • As far as peak fluctuations go, Nephros' Cash from Operations tumbled by 316727.27% in 2022, and later soared by 57472.53% in 2024.
  • Nephros' Cash from Operations (Quarter) stood at -$335000.0 in 2021, then soared by 41.79% to -$195000.0 in 2022, then plummeted by 40.0% to -$273000.0 in 2023, then surged by 574.73% to $1.3 million in 2024, then crashed by 92.36% to $99000.0 in 2025.
  • Its Cash from Operations stands at $99000.0 for Q3 2025, versus $994000.0 for Q2 2025 and $322000.0 for Q1 2025.